-
Mashup Score: 0Defining features of hereditary lobular breast cancer due to CDH1 with magnetic resonance imaging and tumor characteristics - 6 month(s) ago
npj Breast Cancer – Defining features of hereditary lobular breast cancer due to CDH1 with magnetic resonance imaging and tumor characteristics
Source: www.nature.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Subcutaneous plasma-derived C1 inhibitor for long-term prophylaxis during pregnancy and breast-feeding in a patient with factor XII hereditary angioedema - 7 month(s) ago
Hereditary angioedema (HAE) is a disabling and potentially life-threatening disorder characterized by recurrent attacks of swelling. It is often linked to a deficiency or lack of functionality of the C1 esterase inhibitor (C1-INH), which leads to elevated levels of bradykinin. However, HAE can also occur in the presence of normal levels and activity of C1-INH, which is known as nC1-INH-HAE. Up to 25% of nC1-INH-HAE cases exhibit mutations in the factor XII (FXII) gene that cause an increase in levels of activated FXII, which is involved in the production of bradykinin.
Source: www.jaci-inpractice.orgCategories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0Living With Hereditary Angioedema in Australia: Findings From a National Observational Study Using Short Message Service to Monitor the Burden of Disease - 7 month(s) ago
To understand the impact and burden of disease experienced by patients with hereditary angioedema (HAE).
Source: www.jaci-inpractice.orgCategories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0The disease burden and societal costs of hereditary angioedema - 12 month(s) ago
According to the current treatment guidelines, the goals of treatment of patients with hereditary angioedema (HAE) are to achieve total control of the disease and to normalize patients’ lives.
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0Living with hereditary angioedema in Australia: Findings from a national observational study using SMS to monitor the burden of disease - 1 year(s) ago
To better understand the impact and burden of disease experienced by patients with hereditary angioedema (HAE).
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 25Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study - 1 year(s) ago
In our cohort, endoscopic cancer surveillance was an acceptable alternative to surgery in individuals with CDH1 variants who declined total gastrectomy. The low rate of incident tumours (>T1a) suggests that surveillance might be a rational alternative to surgery in individuals with CDH1 variants.
Source: The Lancet OncologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3Precede Consortium > Home - 1 year(s) ago
Precede Consortium
Source: precedestudy.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Epidemiology, Management, and Treatment Access of Hereditary Angioedema in the Asia Pacific Region: Outcomes From an International Survey - 1 year(s) ago
Hereditary angioedema (HAE) is a rare genetic disease with significant morbidity and mortality for which early diagnosis and effective therapy are critical. Many Asia Pacific (AP) countries still lack access to diagnostic tests and evidence-based therapies. Epidemiologic data from the AP is needed to formulate regional guidelines to improve standards of care for HAE.
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0
Article InfoPublication HistoryAccepted: November 25, 2022Received in revised form: November 7, 2022Received: July 15, 2022Publication stageIn Press Journal Pre-ProofFootnotesThis research received no specific grant from any funding agency from the public, commercial, or not-for-profit sectors.Conflict of Interest: Joud…
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0TRENDS IN TREATMENTS WITH DISEASE-SPECIFIC AND INTERFERING DRUGS IN PATIENTS WITH HEREDITARY ANGIOEDEMA IN SWEDEN - 1 year(s) ago
Hereditary angioedema (HAE) is caused by low levels of or defects in C1 inhibitor protein (C1-INH). Although disease activity may be modified by prophylaxis, emergency treatment, treatment for comorbidities, and oral contraceptives, the extent of their use is unclear.
Categories: Allergy-Immunology, Latest HeadlinesTweet
Want to know about MRI and tumor characteristics of #Hereditary Lobular Breast Cancer due to #CDH1? Paper by @LaurenGambleMD out now - https://t.co/fWoVBjRjyP @Nature_NPJ @NCIResearchCtr @NCICCR_SurgOnc @MSKBreastImage @NoStomach4Cancr